![]()
|
|
||||||||
J Biol Chem, Vol. 275, Issue 3, 2219-2230, January 21, 2000
,
From the Department of Pathology, University of Massachusetts Medical School, Worcester, Massachusetts 01655, the § Division of Signal Transduction, Harvard Institutes of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, and ¶ Roche Bioscience, Palo Alto, California 94034
| |
ABSTRACT |
|---|
|
|
|---|
Itk, a Tec family tyrosine kinase, acts
downstream of Lck and phosphatidylinositol 3'-kinase to facilitate T
cell receptor (TCR)-dependent calcium influxes and
increases in extracellular-regulated kinase activity. Here we
demonstrate interactions between Itk and crucial components of
TCR-dependent signaling pathways. First, the
inositide-binding pocket of the Itk pleckstrin homology domain directs
the constitutive association of Itk with buoyant membranes that are the
primary site of TCR activation and are enriched in both Lck and LAT.
This association is required for the transphosphorylation of Itk.
Second, the Itk proline-rich region binds to Grb2 and LAT. Third, the
Itk Src homology (SH3) 3 and SH2 domains interact cooperatively with
Syk-phosphorylated SLP-76. Notably, SLP-76 contains a predicted binding
motif for the Itk SH2 domain and binds to full-length Itk in
vitro. Finally, we show that kinase-inactive Itk can antagonize
the SLP-76-dependent activation of NF-AT. The inhibition of
NF-AT activation depends on the Itk pleckstrin homology domain,
proline-rich region, and SH2 domain. Together, these observations suggest that multivalent interactions recruit Itk to LAT-nucleated signaling complexes and facilitate the activation of LAT-associated phospholipase C The T cell receptor
(TCR),1 B cell receptor, and
mast cell receptor (Fc The Tec family kinases (Tec, Itk, Btk, Bmx, and Txk (21, 22)) also
participate in signal transduction pathways downstream of antigen
receptors (3, 23-31). In particular, Tec kinases have been observed to
contribute to the PI3K-dependent phosphorylation and
activation of PLC Although protein interaction domains have been shown to recruit kinases
to specific complexes containing physiological activators and
substrates, the protein-protein interactions responsible for the
facilitation of calcium influxes and the activation of MAPKs by Tec
family kinases have not yet been identified. Given the similarity of
the phenotypes observed upon the disruption of Src kinases, Syk
kinases, adapter proteins (LAT, SLP-76, and BLNK), and Tec kinases, the
Tec kinases are likely to interact with these proteins in order to
facilitate the formation or activation of a competent signaling
complex. However, the Tec kinase ligands reported to date have not
supported this hypothesis. For example, it has been suggested that Tec
kinase PRRs facilitate the transphosphorylation and activation of Tec
kinases by recruiting Src kinases (44). Unfortunately, the
contributions of Tec kinase PRRs to the physiological transphosphorylation of Tec kinases and to the induction of calcium influxes by antigen receptors remain untested. Furthermore, although ligands have been reported for the SH3 domains of Tec kinases, the SH3
domain does not appear to be relevant to the induction of calcium
influxes (45). In contrast, ligands of the SH2 domains of Tec kinases
remain unknown, yet the SH2 domain is clearly involved in the induction
of calcium influxes and participates in Tec kinase-mediated transformation (39, 45). Since Syk kinases act upstream of the Tec
kinases but do not appear to phosphorylate the Tec kinases (46-48),
Syk kinases may facilitate the recruitment of Tec kinases to sites at
which they encounter either activators (Src kinases) or substrates
(such as PLC The identification of ligands for the protein-interaction domains of
Tec kinases may be complicated by the ability of these proteins to
adopt a closed conformation. This closed conformation depends on
intramolecular interactions between adjacent PRRs and SH3 domains and
severely limits the participation of these domains in intermolecular
interactions (49). To date, the functional consequences of this closed
conformation have not been resolved. However, two lines of evidence
suggest that the closed conformation limits the activity of Tec
kinases. First, the deletion of the SH3 domain, which releases the Tec
kinase PRR from intramolecular sequestration, potentiates both antigen
receptor-dependent calcium influxes and
Btk-dependent transformation (45, 50). Second, Tec kinase
autophosphorylation is strongly correlated with Tec kinase activation
and is likely to disrupt the closed conformation, since the primary
site of autophosphorylation is a tyrosine residue in the ligand-binding
pocket of the SH3 domain
(51-53).2 Although the SH2
domain contributes to the stabilization of the closed conformation, the
sequestration of the SH3 domain and PRR can be reversed by exposure to
highly tyrosine-phosphorylated lysates (49), implying that
intermolecular interactions driven by the SH2 domain may also
antagonize the closed conformation of Tec kinases.
In this article we report the identification of ligands for the
homology domains of Itk in both Jurkat T cells and in primary murine
CD4+ T cells. These observations suggest a model in which
multivalent interactions overcome the closed conformation in order to
recruit Itk to a LAT-nucleated signaling complex and facilitate the
activation of LAT-associated PLC Antibodies--
Hybridomas producing monoclonal antibodies
(mAbs) specific for hemagglutinin (HA, 12CA5), CD3 Expression Vectors--
The native stop codon of Itk was deleted
and replaced with a PCR-derived fragment encoding a short linker
peptide and a carboxyl-terminal Myc epitope tag. These modifications
extend Itk by 21 amino acids (AGAEFMEQKLISEEDLRKFDI). EF/Itk-myc
expression vectors were generated by inserting the modified Itk
cDNA into a derivative of pEF-BOS (54). EF/Itk-KR-myc includes a
kinase-inactivating mutation (K390R (24)). Mutations inactivating the
proline-rich region (P158A, P159A; PR*) and the binding pockets of the
PH domain (R29C; Xid), SH3 domain (W208K; SH3*), and SH2 domain (R265A;
SH2*) were introduced by either site-directed or PCR-directed
mutagenesis. The EF/HA:SLP-76 expression vector was generated by
subcloning the SLP-76 coding region into a transfer vector, and then
into pEF-HA. This results in the insertion of a short linker-derived peptide (RSRTSGSPGRAA) between the triple-HA epitope tag present in
pEF-HA (a kind gift of Anjana Rao) and the original start codon of
SLP-76.
GST-Itk Fusion Proteins--
GST fusion proteins were prepared
as described previously (49, 55). Briefly, inserts encoding the desired
domains of Itk were generated by PCR and subcloned into the
BamHI site of pGEX-2T. The TEC-, SH3-, and SH2-5' primers
encode Itk products beginning at amino acids 97, 171, and 231, respectively. The TEC-, SH3-, and SH2-3' primers terminate at amino
acids 174, 232, and 338, respectively. The soluble TEC fragment was
prepared by thrombin cleavage of the TEC fusion protein as recommended
by the manufacturer (Amersham Pharmacia Biotech).
Binding Properties of the Itk SH2 Domain--
The Itk SH2 domain
binding motif was obtained by the method of Songyang and Cantley (56),
with minor modifications (57). In contrast to previous reports, the
bound phosphopeptide mixture was eluted with 30% acetic acid rather
than phenyl phosphate. The relative enrichments displayed in Fig.
5A were obtained normalizing the abundance (mol %) of amino
acids in the bound mixture to their abundance in the starting library.
Unlike previous reports of SH2 domain binding motifs, these data were
not background corrected by subtracting the amino acid abundances
observed after purification over GST prior to normalization. For
comparison, the selection for proline at pY+3 is exceptionally strong,
and is roughly equivalent to the selection of asparagine at pY+2 by the
Grb2 SH2 domain.
Generation of Itk Overexpressing Stable Lines--
Jurkat cells
were transfected with 1 µg of pBJneo and either 10 µg of the empty
pEF-HA expression vector, EF:Itk-KR-myc, EF:Itk-Xid/KR-myc, or
EF:Itk-PR*/KR-myc, as described (24). Stable cell lines were derived by
selection in 1.4 mg/ml G418 (Life Technologies, Inc.). Lines expressing
Itk-myc at approximately endogenous levels were expanded for use in
subsequent experiments. These lines were determined to express normal
levels of CD3 Baculoviruses--
The GST:Syk baculovirus was provided by Ian
MacNeil (Ariad Pharmaceuticals, Cambridge, MA) and results in the
expression of a GST fusion of full-length Syk. The Lck and Itk
baculoviruses have been described (24). The HA:SLP-76 baculovirus was
derived from the EF/HA:SLP-76 expression vector in the same manner.
Cell Culture--
Sf9 cells, Jurkat cells (clone E6.1),
and Jurkat derivatives were maintained, stimulated, and lysed as
described (24, 49).
Expansion of Murine CD4+ Peripheral
Lymphocytes--
CD4+ T cells were purified from murine
spleens by removing red blood cells with red blood cell lysis buffer
and killing CD8+ T cells by incubation with anti-CD8
antibody (3.155) followed by complement (Cedarlane). Live lymphocytes
were isolated and stimulated with 10 ng/ml PMA and 2 µg/ml
concanavalin A. Cells were rinsed into interleukin-2-containing media
at 2, 4, and 6 days after the initiation of the cultures. By day 8 the
TCR+ CD4+ T cells had expanded approximately
100-fold and represented greater than 95% of the cells in culture, as
assayed by FACS. These cells were rested 1 h at 37 °C in the
absence of interleukin-2 prior to stimulation. The CD4+ T
cells were stimulated by preincubating with biotinylated antibodies to
both CD3 Cellular Fractionation--
This protocol was adapted from
previously described methods for the isolation of buoyant membranes
(58-60). Both unstimulated and OKT3-stimulated Jurkat cells
(108) were washed twice in ice-cold phosphate-buffered
saline with 20 mM sodium fluoride and 1 mM
sodium orthovanadate and resuspended in 1.6 ml of ice-cold
homogenization buffer (20 mM Hepes, pH 7.4, 1 mM dithiothreitol, 2 mM MgCl2, 1 mM sodium orthovanadate, 12.5 mM KCl, 5 mM sodium fluoride, and 5 mM sodium
pyrophosphate, supplemented with protease inhibitors
phenylmethylsulfonyl fluoride, pepstatin A, aprotinin, and leupeptin
(Sigma)). Cells were homogenized on ice using a Dounce homogenizer.
Total homogenates were adjusted to gradient buffer conditions by the
addition of homogenization buffer with concentrated salts. Gradient
buffer contained 50 mM KCl, 20 mM sodium
fluoride, and 20 mM sodium pyrophosphate, but was otherwise
identical to homogenization buffer. Homogenates were adjusted to the
desired density by the addition of 80% sucrose (w/v) in gradient
buffer. The diluted homogenate was loaded into a SW41 ultracentrifuge
tube and a gradient was created by successively overlaying 1-ml steps
of the indicated sucrose solutions, also in gradient buffer. The step
gradients were ultracentrifuged for 16 h at 39,000 rpm and at
4 °C. Fractions were removed in 0.5-ml aliquots and the pellet was
rinsed once in 0.5 ml of gradient buffer, then resuspended by
sonication in 0.5 ml of gradient buffer. 20 µl of each fraction was
analyzed without concentration by Western blotting; thus each gel
represents the total protein content from 20/500 (4%) of
108 cells. Optical density at 600 nm (Beckman DU-600
spectrophotometer) was used to monitor light scattering by vesicular
structures (58). Protein content was determined by Bradford assay
(Bio-Rad).
Lipophilic Fluorescent Dyes--
DiI-C18 (3),
FAST-DiI (DiI Surface Biotinylation--
Jurkat cells were rinsed three times
in phosphate-buffered saline supplemented with 1 mM
MgCl2 and 0.1 mM CaCl2, resuspended at 2 × 107 cells/ml in rinse buffer, and incubated at
4 °C with 1 mg/ml Sulfo-NHS-LC-biotin (Pierce) for 30 min. Excess
labeling reagent was quenched by a 10-min incubation in rinse buffer
supplemented with 50 mM glycine. Finally, the labeled cells
were rinsed three times in rinse buffer prior to homogenization.
Modifications to Cellular Fractionation Procedures--
Jurkat
homogenates were prepared as descibed above. Prior to the addition of
80% sucrose various manipulations were performed. These homogenates
were either untreated, cleared of nuclear material by a 10 min spin at
1000 × g and 4 °C, or adjusted to 0.5% Triton X-100. Membranes were also prepared from cleared homogenates by pelleting at 100,000 × g and 4 °C for 1 h. In
the latter case, the pelleted material was rinsed clean and resuspended
by sonication in an equivalent volume of homogenization buffer. The
treated homogenates and purified membranes were adjusted to 80%
sucrose and fractionated as described above. When included, Triton
X-100 was present throughout the gradient at 0.5%.
Binding Assays--
Binding assays and peptide competition
assays were performed as described (55, 56). SLP-76 peptides were
provided by Paul Findell (Roche Bioscience, Palo Alto, CA). The full
phosphotyrosine-containing peptides are FEEDDpYYESPNDD (Y113),
EDDGDpYYESPNE (Y128), EDDADpYEPPPS (Y145), EEWYVSpYITRPEAE (Y426), and
QKESQVpYLLGTGLR (Y483); the proline-rich peptides are fully described
in figures. The high affinity Itk SH3 domain ligand GWYSKPPPPIP has
been described (55). The phosphopeptide EEVpYENVHS, based on a Grb-2
SH2 domain-binding site in the tail of SHP-1, was synthesized by
Michael Burne at the Tufts University peptide facility.
Immunoprecipitations and Western Blotting--
Itk-myc was
immunoprecipitated from 2 × 107 Jurkat cells using 2 µg of the 9E.10 mAb prebound to 20 µl of recombinant protein G-Sepharose (Life Technologies, Inc.). The in vitro
reconstitution of the interaction between SLP-76 and Itk was performed
by prebinding the anti-HA mAb 12CA5 to protein A-Sepharose and
incubating aliquots of the 12CA5-Sepharose beads with saturating
amounts of baculoviral HA:SLP-76. The resulting HA:SLP-76-Sepharose
beads were rinsed extensively and incubated with fresh Sf9
lysates containing Itk for 3 h at 4 °C. Recombinant GST-Grb2
(Santa Cruz Biotechnology) was added to the indicated incubations at 2 µg/ml. Western blotting protocols have been described elsewhere
(55).
Secreted Alkaline Phosphatase Assays for NF-AT
Activation--
Jurkat/Tag cells were transiently transfected by
electroporating 2 × 107 cells in 0.4 ml of RPMI 1640, 25 mM HEPES, and 2 mM glutamine at 310 V and
960 microfarads with 10 µg of pSX-NFAT/SEAP and a total of 40 µg of
pEF-BOS-derived vector. EF/HA:SLP-76 or pEF-HA accounted for 20 µg of
this total, and the EF/Itk-myc variants or pEF-HA accounted for the
remaining 20 µg of this total. After 24 h each transfection was
split into 8 pools. These pools were transferred, in duplicate, to
24-well plates which were untreated, coated with OKT3 ascites, or
contained 10 ng/ml PMA and 1 µM ionomycin. The remaining
two pools were used to confirm the uniform overexpression of SLP-76 and
Itk. After 18 h of stimulation, the supernatants were assayed, in
triplicate, for SEAP activity by the method of Spencer et
al. (61). The results presented were normalized to a percentage of
the response to PMA and ionomycin.
Itk Is Present in Surface-exposed Buoyant Vesicles Similar to
GEMs--
The PH domain of Itk has been shown to be required for the
PI3K-dependent recruitment of Itk to COS cell membranes
(40), but the specific role of the lipid binding pocket of the PH
domain has not been assessed. In order to determine the contribution of
the lipid binding pocket of the Itk PH domain to the membrane recruitment of Itk in T lymphocytes, we used an assay for membrane association which is based on the buoyant density of membrane vesicles
prepared by mechanical disruption in the absence of detergents. Our
procedure is based on the method of Bourguignon et al. (58), and is similar to methods commonly used for the preparation of both
caveolae and detergent-resistant structures variously referred to as
lipid rafts, GEMs (glycosphingolipid-enriched membranes), detergent-insoluble GEMs, and detergent-insoluble membranes
(62-65).
This method generated at least three populations of buoyant vesicles
(20-30, 35, and 50% sucrose) and a pellet containing dense or
insoluble material, as indicated in Fig.
1A. The buoyant density of the
least dense population of vesicles observed by this method was similar
to that of GEMs observed in T cells in previous studies, suggesting
that these structures may be related (14, 66). In addition, the
distributions of fluorescent lipid analogues within these gradients
were compatible with predictions based on the composition of GEMs.
Whereas light vesicles were preferentially enriched in
BODIPY-sphingomyelin and DiI, which contain two saturated
C18 acyl chains, FAST-DiI, which contains two unsaturated
C18 acyl chains, was preferentially enriched in the 50%
sucrose fractions (Fig. 1B). Furthermore, these light vesicles contained many proteins characteristic of GEMs, including LAT
(Fig. 1C), Lck (Fig. 2), Fyn
(data not shown), and heterotrimeric G protein subunits (data not
shown).
Strikingly, both Itk and CD3
Based on surface biotinylation, the light vesicles we detected were
surface-exposed, suggesting that they are at least in part derived from
the plasma membrane (Fig. 1C). Under the conditions used,
most surface-exposed proteins were found in the insoluble pellet, and
could be cleared from the lysates by a brief low speed centrifugation.
This indicates that light vesicles are a specific subset of the total
plasma membrane. The absence of both LAT and calnexin from the
insoluble pellet proved that the presence of surface biotinylated
proteins in the pellet was not a trivial result of incomplete cell
disruption. Light vesicles were also distinct from the endoplasmic
reticulum, as low speed centrifugation cleared the lysates of calnexin,
an endoplasmic reticulum marker, without affecting the amounts of LAT,
Itk, and CD3 Itk Containing Buoyant Vesicles Are Involved in TCR-Proximal
Responses--
Since the light vesicles shared many characteristics
with lipid rafts, which have been proposed to act as sites of signal initiation (70-72), we wished to determine if
TCR-dependent signals were initiated in light vesicles. In
order to address this question we fractionated homogenates of Jurkat
cells stimulated for varying times and analyzed the distributions of
signaling molecules within the resulting gradients (Fig. 2). TCR
A more extensive time course (data not shown) revealed that changes in
the gel-mobility of light vesicle-associated Lck were apparent within
15 s of TCR ligation, and that the recruitment of ZAP-70 to the
light vesicles could be observed within the same time frame. The
recruitment of Grb2 to the light vesicles lagged slightly, and was
maximal between 30 s and 2 min after TCR cross-linking. ERK
activation, as assayed by Western blotting with phosphorylation site-specific antibodies, was not detected until 1 min after TCR cross-linking. Interestingly, peak tyrosine phosphorylation occurred in
the cytosolic fractions between 2 and 5 min. These data suggested that
TCR-mediated responses are specifically initiated in the light
vesicles; therefore, the association of Itk with the light vesicles may
be critical for the activation of Itk downstream of the TCR.
The Inositide Binding Pocket of the Itk PH Domain Is Required for
Itk Transphosphorylation--
The PH domains of Tec kinases have been
proposed to mediate membrane recruitment required for the
transphosphorylation of Tec kinases by Src kinases. Additionally, the
PRR present in Tec kinases has also been proposed to promote the
transphosphorylation of Tec kinases by promoting a direct interaction
with Src kinase SH3 domains (44). In order to compare the contributions
of the lipid binding pocket in the Itk PH domain and the Itk PRR to the transphosphorylation of Itk we generated expression vectors encoding Myc-tagged kinase-dead Itk (Itk-KR-myc) with or without additional mutations in the lipid binding pocket of the PH domain or the PRR (Xid
or PR*, Fig. 3A). These
vectors were used to establish stable Jurkat cell lines expressing
variants of Itk-myc KR at approximately the same level as wild-type
Itk. These cell lines were stimulated with pervanadate, and the
transphosphorylation of the epitope-tagged Itk was assessed by
anti-phosphotyrosine immunoblotting. These experiments revealed that
the inositide binding pocket of the PH domain, but not the PRR, was
required for the transphosphorylation of Itk (Fig. 3B).
Fractionation experiments also demonstrated that the
transphosphorylation of Itk correlated strictly with the light vesicle association of Itk (Fig. 3C). In addition, in
vitro binding assays indicated that although the Itk PRR is
capable of binding many SH3 domains, including the Fyn SH3 domain, it
cannot bind to the Lck SH3 domain (Fig. 3D). Since the
transphosphorylation of Itk in Jurkat cells depends on Lck, rather than
Fyn (23, 24), these data support a model in which productive
interactions between Itk and Lck require their colocalization in lipid
raft-like structures.
Interactions of the Itk Homology Domains--
Although the Itk PH
domain clearly has a dominant role in the transphosphorylation of Itk
by Src kinases, the remaining Itk homology domains may facilitate the
colocalization of Itk with activating receptors or with
substrate-containing complexes. In order to identify binding proteins
for the Itk PRR, SH3 domain, and SH2 domain we performed binding assays
using GST-Itk fusion proteins (Fig.
4A). We used lysates of
CD4+ murine T cell lines stimulated with antibodies to both
CD3
The proteins bound by the Itk-domain fusion proteins included 150, 120, 95, 76, 70, and 36-kDa tyrosine phosphoproteins (Fig. 4B).
These bands corresponded to PLC Identification of a Binding Motif for the Itk SH2
Domain--
Since SLP-76 was the most prominent TCR-induced tyrosine
phosphoprotein bound to the Itk SH2 domain in both murine T cells and
Jurkat T cells (Fig. 4B and data not shown), we suspected that phosphorylated SLP-76 could bind directly to the Itk SH2 domain.
This hypothesis was supported by the observation that the Itk SH2
domain could precipitate SLP-76 from denatured lysates (data not
shown). In order to facilitate the identification of Itk SH2
domain-binding sites in SLP-76 we determined a consensus binding motif
for the Itk SH2 domain using oriented peptide library screening. A
summary of the enrichment values for the most strongly selected
residues at each position is shown in Fig.
5A. The Itk SH2 domain
displays a strong preference for alanine and glutamate at the first
degenerate position (pY+1), moderate preferences at the second
degenerate position (pY+2), and an exceptionally strong preference for
proline at the third degenerate position (pY+3). Notably, the SH2
domains of Vav and Nck share a strong preference for proline at pY+3
(56, 73). This is striking since Vav and Nck have been shown to
interact with the predicted Itk SH2 domain-binding sites in SLP-76 (9,
74-76). Finally, the binding motif of the Itk SH2 domain predicts
binding sites in BLNK and CD19, as well as Syk, ZAP-70, and SLP-76
(Fig. 5B). Thus, direct biochemical interactions mediated by
the SH2 domains of Tec kinases may link the Tec kinases to mediators of
antigen-induced calcium influxes in multiple systems (17, 77-79).
Characterization of the Interaction between Itk and
SLP-76--
The predicted Itk SH2 domain-binding sites in SLP-76 (Fig.
5B) are known to be ZAP-70/Syk substrates (6). To confirm
that these sites in SLP-76 were capable of binding the Itk SH2 domain, we tested the ability of the Itk SH2 domain to precipitate HA-tagged SLP-76 which had been expressed alone in Sf9 cells, or
co-expressed with either Lck or GST:Syk (Fig. 5C). As
expected, the binding of SLP-76 to the Itk SH2 domain was induced by
the co-expression of SLP-76 with Syk, but not Lck. Further confirmation
that the Syk-phosphorylation sites in SLP-76 are capable of binding to the Itk SH2 domain was obtained by using SLP-76-derived phosphopeptides in competition assays (Fig. 5D). For comparison, a
phosphopeptide based on a predicted Grb2 SH2 domain-binding site
(pYENV) in SHP-1 was included in these assays. The pYEPP peptide
corresponding to tyrosine 145 in SLP-76 was the most effective (pY145)
at inhibiting the interaction between the Itk SH2 domain and
pervanadate-phosphorylated SLP-76; the pYENV peptide and the pYESP
peptide corresponding to tyrosine 113 in SLP-76 (pY113) were marginally
less effective. A second pYESP-containing peptide corresponding to
tyrosine 128 in SLP-76 (pY128) was observed to inhibit binding of total
tyrosine phosphoproteins to the Itk SH2 domain at 1 mM
(data not shown), but bound the Itk SH2 domain with substantially lower
affinity than the other peptides. As expected, the remaining peptides, pYITR (pY426) and pYLLG (pY483), did not detectably inhibit the binding
of SLP-76 to the Itk SH2 domain. The inability of the pY113 and pY145
peptides to compete with phospho-LAT for binding to the Grb2 SH2 domain
confirmed the specificity of these peptides for the Itk SH2 domain
(Fig. 5E). These data suggest that Itk is recruited to
SLP-76 following the phosphorylation of SLP-76 by ZAP-70. The Syk
kinase-dependent recruitment of Tec kinases to signaling
complexes, such as the LAT·SLP-76 complex, could explain the apparent
placement of Syk kinases upstream of Tec kinases.
Since the Itk SH3 domain also appeared to bind SLP-76 directly (Fig.
5C) we also mapped Itk SH3 domain-interacting sites in SLP-76 by peptide competition (Fig. 5F). Candidate Itk SH3
domain-binding sites within SLP-76 were identified by similarity to
predicted Itk SH3 domain binding motifs (KXXPPXP
and PPXPXXR (55)). For comparison, a high
affinity SH3 domain-binding peptide was also included in these assays
(GWYSKPPPPIP (55)). The SLP-76 peptide 196-208 competed with SLP-76
for binding to the Itk SH3 domain and conforms exactly to the class II
binding motif found in all previously identified Itk SH3 domain ligands
(PPPPXXR). However, SLP-76 peptide 184-195 bound even more
tightly and contains a related proline-rich sequence (PPVPPQR). The
putative binding sites within SLP-76, peptides 184-195 and 196-208,
are adjacent to the optimal Itk SH2 domain-binding site, pY145. The
presence of adjacent binding sites for the Itk SH3 and SH2 domains
within SLP-76 suggested that SLP-76 could bind synergistically to the Itk SH3 and SH2 domains.
Multivalent Interactions Antagonize the Intramolecular Interaction
Sequestering the Itk PRR and SH3 Domain--
Previously, we proposed
that ligands capable of forming bidentate interactions with the Itk SH3
and SH2 domains could overcome the intramolecular sequestration of the
Itk PRR and SH3 domain, altering the conformation of Itk (49). Since
the results described above suggested that SLP-76 might be capable of
acting in this manner, we wished to determine if the Itk SH3 domain and
SH2 domain could engage SLP-76 synergistically. Thus, we assessed the
relative contributions of these two domains of Itk to the binding of
SLP-76 using peptide competitors. For these experiments we used the
high affinity Itk SH3 domain ligand described above (GWYSKPPPPIP) and the SLP-76-derived pY145 phosphopeptide to compete with
pervanadate-phosphorylated SLP-76 for binding to the Itk SH32 and TEC2
fusion proteins. In each case, the maximal inhibition of SLP-76 binding
was only observed when both peptides were present (Fig.
6A). We also tested the relative contributions of the Itk PRR, SH3 domain, and SH2 domain to
the engagement of SLP-76 using a panel of point mutant Itk TEC2 fusion
proteins. These experiments confirmed that the Itk SH3 and SH2 domains
each contribute to SLP-76 binding, even in the context of the
conformationally closed TEC2 fusion protein (Fig. 6A)).
Since the contribution of the Itk SH3 domain to the interaction with
SLP-76 must come at the expense of its involvement in the sequestration
of the Itk PRR, the engagement of SLP-76 must induce a conformational
change in Itk.
We expected that the occupation of the Itk SH3 domain by SLP-76 would
promote Grb2-mediated interactions between the Itk PRR and LAT,
stabilizing Itk in a LAT-nucleated, SLP-76-containing complex. To mimic
the effects of a bidentate interaction between Itk and SLP-76 we
limited the availability of the Itk SH3 domain present in the TEC2
fusion protein. As expected, the inactivation or occupation of the Itk
SH3 domain promoted the interaction of LAT with the TEC2 fusion protein
(Fig. 6B). Vav, a member of the LAT·SLP-76 complex, also
bound more effectively to the SH3 domain-mutant TEC2 fusion protein.
The contribution of the Itk PRR to the interaction between the TEC2
fusion protein and LAT was confirmed by inactivating the Itk PRR (Fig.
6B). In contrast, Cbl, a direct ligand of the Itk SH3
domain, depended on the Itk SH3 domain for its interaction with the
TEC2 fusion protein (Fig. 6B). Thus, conformational changes induced in Itk as a result of its bidentate interaction with SLP-76 could facilitate Grb2-mediated interactions between Itk and the LAT-nucleated signaling complex. Furthermore, the autophosphorylation of the Itk SH3 domain could have a similar effect on the ability of Itk
to interact with LAT through the Itk PRR.
In Vitro Reconstitution of the Interaction between Itk and
SLP-76--
In order to demonstrate that an intramolecular interaction
similar to that observed in the Itk TEC2 fusion protein also occurs in
full-length Itk, we performed a series of in vitro binding assays. First, we compared the ability of full-length Itk to bind SLP-76 to the ability of a GST-Itk chimera lacking the amino terminus of Itk (see Fig. 4A, GST-32KR) to bind SLP-76. As we
expected, the GST fusion protein, but not full-length Itk, bound to
Sepharose beads baited with unphosphorylated SLP-76, implying that the
Itk SH3 domain is sequestered in the context of full-length Itk (data not shown). Second, by baiting beads with differentially phosphorylated SLP-76 we established that Syk-phosphorylated SLP-76 is capable of
binding full-length Itk, despite the sequestration of the Itk SH3
domain (Fig. 7). Finally, the involvement
of the Itk SH3 domain in the interaction between full-length Itk and
Syk-phosphorylated SLP-76 was suggested by the observation that the
addition of soluble GST-Grb2 to these binding assays promoted the
interaction between Itk and SLP-76 (Fig. 7). These experiments are
consistent with a model in which Grb2 stabilizes bidentate interactions
between Syk-phosphorylated SLP-76 and full-length Itk by occupying the Itk PRR and limiting its ability to compete with SLP-76 for access to
the Itk SH3 domain. Based on the biochemical evidence presented above,
this interaction could occur in the context of a lipid raft-associated
LAT-nucleated signaling complex.
Itk Antagonizes the Effect of SLP-76 on NF-AT
Transcription--
Since biochemical studies in Itk-deficient T cells
revealed that Itk is required for the activation of MAPKs and calcium
influxes downstream of the TCR, we expected that Itk would contribute
to the TCR-dependent activation of the nuclear factor of
activated T cells (NF-AT) (35, 80). This would be consistent with a role for Itk downstream of LAT and SLP-76, which are required for the
activation of NF-AT, the activation of MAPKs, and the activation of
calcium influxes (18, 20). Because SLP-76 promotes transcription from
NF-AT response elements, we wished to test the ability of
kinase-inactive Itk to inhibit NF-AT-dependent transcription in the presence or absence of SLP-76 (81). We found that
kinase-inactive Itk suppressed the ability of SLP-76 to enhance both
basal and TCR-induced transcription from NF-AT response elements, and
thus acted as a dominant-negative inhibitor of this signaling pathway
(Fig. 8A). Kinase-inactive Itk
also suppressed the TCR-induced activation of NF-AT in the absence of
exogenous SLP-76. These results suggested that SLP-76 and Itk may
interact in vivo.
Unexpectedly, kinase-active Itk also suppressed the ability of SLP-76
to enhance transcription from NF-AT response elements (Fig.
8A). This revealed that Itk catalytic activity is not
limiting for the activation of NF-AT in Jurkat cells, and furthermore, that the inhibition of NF-AT mediated by kinase-inactive Itk does not
depend on the exclusion of catalytically active Itk from its normal
sites of action. Instead, we postulate that this transcriptional suppression arises from competition between Itk and other effector molecules for access to a limiting number of functional docking sites
in the LAT·SLP-76 complex. In order to identify the domains contributing to the suppression of SLP-76-mediated transcription, we
assessed the ability of domain-inactivated variants of Itk to suppress
SLP-76-dependent NF-AT activation. These experiments revealed that the binding properties of the Itk PH domain, PRR, and SH2
domain were all required for the suppression of
SLP-76-dependent NF-AT activation by Itk (Fig.
8B).
The PH domains of Tec kinases bind PtdIns(3,4,5)P3 and
have been shown to mediate the PI3K-dependent recruitment
of Tec kinases to the plasma membrane (see Fig.
9). In this article we confirm that the
inositide binding pocket of the Itk PH domain is required for the
membrane localization of Itk. Furthermore, we demonstrate that the
lipid binding pocket of the Itk PH domain directs the association of
Itk with a specific subset of the plasma membrane that is similar in
composition to lipid rafts. This raft-related subset of the plasma
membrane is enriched in Itk, as well as TCR subunits, Lck, and LAT, and
is involved in signaling events immediately proximal to the TCR.
1 by Itk.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
RI) are composed of multiple subunits,
enabling the coupling of a variable antigen-recognition subunit to
conserved signaling modules (1-3). Collectively, these receptors
direct the antigen-specific responses of T cells, B cells, and mast
cells. Although these antigen receptors do not contain intrinsic
tyrosine kinases, the early events downstream of these antigen
receptors are controlled by a relatively conserved series of tyrosine
kinase-dependent events. In each case, Src family kinases
initiate the signaling cascade by phosphorylating immunoreceptor
tyrosine-based activation motifs present in the cytoplasmic tails of
the signal-transducing receptor subunits. Complete immunoreceptor
tyrosine-based activation motifs phosphorylation results in the
recruitment of Syk/ZAP-70 family tyrosine kinases to the receptor.
These kinases are subsequently activated by Src kinase-mediated
transphosphorylation. The substrates of the Syk kinases include
internal phosphorylation sites as well as transphosphorylation sites in
LAT, SLP-76, and BLNK, a SLP-76-related adapter protein (1, 4-7).
These Syk kinase-dependent phosphorylations direct the
recruitment of additional effector and adapter molecules to LAT,
SLP-76, BLNK, and the Syk kinases themselves (7-13). In T cells LAT,
which is recruited into lipid rafts by dual palmitoylation, nucleates a
raft-associated complex containing multiple effectors, including Grb2
and Sos, Gads and SLP-76, Cbl, Vav, PLC
1, and PI3K (5, 14, 15). The
perturbation of this complex by the disruption of Lck, ZAP-70, LAT, or
SLP-76 results in profound defects in the activation of calcium
influxes and mitogen-activated protein kinases (MAPKs) downstream of
the TCR (16-20). Similar complexes may form in both B cells and mast cells.
isoforms, the concomitant induction of sustained
calcium influxes (32), and the activation of MAPKs (33-35). However,
the mechanisms that integrate the Tec kinases into antigen
receptor-dependent signaling pathways are not yet well
understood. Structurally, these kinases share the conserved arrangement
of SH3, SH2, and kinase domains found in Src kinases, but are
distinguished by the absence of amino-terminal acylations, the absence
of the carboxyl-terminal regulatory tyrosine, and by the presence of a
conserved amino-terminal region containing a pleckstrin homology (PH)
domain, a Btk homology motif, and a proline-rich region (PRR). Although
the functions of the protein-binding domains of Tec kinases remain
unclear, the phosphatidylinositol 3,4,5-trisphosphate
(PtdIns(3,4,5)P3) binding pocket present in Tec kinase PH
domains is clearly required for the cooperative activation of PLC
isoforms by PI3K and Tec kinases (32). The importance of the PH domain
is underscored by the observation that its disruption can result in
immunological disorders in both humans (XLA) and mice (Xid) (36). This
lipid-protein interaction directs the recruitment of Tec kinases to the
plasma membrane and facilitates their transphosphorylation and
activation by Src kinases (23, 24, 37-43).
) by generating docking sites for Tec kinase SH2
domains. Since the substrates of the Syk kinases include LAT, SLP-76,
BLNK, and the Syk kinases themselves, interactions mediated by Tec
kinase SH2 domains may recruit the Tec kinases into complexes with
physiologically relevant partners.
1 by Itk.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
(OKT3), CD8
(3.155), and c-Myc (9E.10) were purchased from ATCC and antibodies were
used as ascites fluid or purified as described (24). Polyclonal
antisera against Sam68, Vav, Cbl, Fyn, CD3
, and Grb-2, and mAbs
against Lck and TCR
were purchased from Santa Cruz Biotechnology.
The anti-CrkL antiserum and the anti-ZAP-70 and anti-SHP-2 mAbs were
purchased from Transduction Laboratories. The anti-LAT antiserum was
purchased from Upstate Biotechnologies Inc. The murine monoclonal
antibody against HS-1 (3A3) was purchased from MBL International Corp. 4G.10, a murine monoclonal antibody recognizing phosphotyrosine, was
the kind gift of Brian Druker (Oregon Health Sciences University, Portland, OR). The anti-SLP-76 murine monoclonal antibody H3 (6) and
the anti-Itk monoclonal antibodies 2F12 and 10B2 (24) have been
described previously. Biotinylated and fluorochrome-conjugated antibodies to murine CD3
and CD4 were purchased from Pharmingen.
by flow cytometry (FACScan, Beckton Dickinson).
and CD4 (10 µg/ml each) at 4 °C for 10 min and
shifting to 37 °C upon the addition of streptavidin (25 µg/ml).
After 2 min of stimulation, lysates were prepared as described.
9, 12-C18 (3)), and BODIPY FL
C5-sphingomyelin were obtained from Molecular Probes. Dye stocks were prepared in ethanol at 2 mg/ml. Jurkat cells were incubated
with the dyes (1:200) for 30 min at 37 °C, and washed extensively
prior to homogenization. After fractionation, fluorescence measurements
were taken in a fluorimeter using dye-matched excitation and emission filters.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (22K):
[in a new window]
Fig. 1.
GEM-like buoyant vesicles can be
prepared in the absence of detergents. A, buoyant
membranes were isolated from Jurkat cells by lysing cells in hypotonic
buffer in the absence of detergent followed by sucrose gradient
fractionation. Protein concentration and optical density of gradient
fractions are shown. B, Jurkat cells were incubated with
either FAST-DiI (DiI
9, 12-C18(3)),
DiI-C18(3), or BODIPY FL C5-sphingomyelin for
30 min at 37 °C prior to homogenization. Relative fluorescence was
determined using appropriate excitation and emission wavelengths.
C, surface biotinylated Jurkat cells were fractionated in
the presence (left panel) or absence (center and
right panels) of 0.5% Triton X-100. In one case
(right panels) insoluble material was cleared from the
initial homogenate prior to fractionation by one 10-min spin at
1000 × g and 4 °C. Biotinylated proteins were
detected by blotting with a streptavidin-horseradish peroxidase
conjugate (only one representative strip is shown); all other proteins
were detected by standard Western blotting.

View larger version (66K):
[in a new window]
Fig. 2.
Signal initiation occurs in the light
vesicles. Jurkat cells were preincubated for 15 min on ice in the
presence or absence of OKT3 (3 µg/ml). Cells were stimulated at
37 °C for the indicated times by the addition of rabbit anti-mouse
IgG (15 µg/ml). Homogenates and gradients were generated as
described. The resulting fractions were analyzed by Western blotting.
Phospho-TCR
was detected with the anti-phosphotyrosine mAb
4G.10.
were constitutively enriched in the
light vesicle fractions (Fig. 1C). The amount of Itk
observed in the light vesicle fractions was somewhat variable, ranging from 10 to 25% (data not shown). Both Itk and CD3
were also present in the insoluble pellet. The Itk and CD3
present in the pellet resisted detergent extraction and could be cleared by low speed centrifugation, suggesting that they may be directly associated with
the cytoskeleton (67) (Fig. 1C). Substantial amounts of Itk
were also present in the 50% sucrose fractions. This pool of Itk could
not be pelleted by centrifugation at 100,000 × g in
low sucrose, and is therefore freely soluble (data not shown).
found in the buoyant fractions (Fig. 1C).
However, the light vesicles derived by this procedure were relatively
sensitive to detergent extraction, and only proteins present in the
fractions with the lowest buoyant density resisted extraction by 0.5%
Triton X-100 (LAT, Fig. 1C; Lck, data not shown). Similar
observations have been made by others (68, 69).
,
Lck, and LAT were all present in the light vesicles, and the fraction
of these proteins present in the light vesicles did not change
significantly following TCR stimulation (data not shown). In contrast,
ZAP-70, Grb-2, and CrkL were recruited to light vesicles after TCR
stimulation. This recruitment was very rapid, and paralleled the
tyrosine phosphorylation of TCR
, which peaked at 30 s. The
recruitment of these molecules was also transient, and declined within
2 min, despite the persistence of tyrosine-phosphorylated TCR
. The
transience of the recruitment of ZAP-70 to the light vesicles may
explain our ability to detect an unusually high stoichiometry of ZAP-70
recruitment, as previous studies did not examine time points earlier
than 2 min post-stimulation (5, 66). Unexpectedly, we did not observe
any changes in the distribution of Itk following stimulation.

View larger version (23K):
[in a new window]
Fig. 3.
Relative roles of Itk PRR and PH domain in
the transphosphorylation of Itk. A, Itk expression
constructs indicating the positions of domain-inactivating mutations.
B, Jurkat subclones stably expressing the indicated variants
of Itk were stimulated with pervanadate (PV) and Itk KR-myc
was immunoprecipitated. The resulting immunoprecipitates were analyzed
for Itk content (Itk) and tyrosine phosphorylation
(pY) by Western blotting. C, Jurkat subclones
stably expressing the indicated variants of Itk were homogenized and
fractionated. The resulting fractions were analyzed for endogenous Itk
(Itk) or transfected Itk variants (Itk-myc) by Western blotting.
D, the immobilized TEC fusion protein, which contains the
Itk PRR (see Fig. 5A), was cleaved by thrombin treatment.
The resulting Itk-TEC fragment was isolated and then incubated with the
indicated SH3 domains. The bound Itk-TEC fragment was detected by
Western blotting with the anti-Itk mAb 10B2.
and CD4 for these binding assays, which allowed us to avoid
artifacts of cellular transformation/immortalization and to take
advantage of the augmentation of TCR-dependent signals by
the CD4 coreceptor.

View larger version (46K):
[in a new window]
Fig. 4.
Identification of tyrosine phosphoproteins
binding the Itk PRR, Itk SH3 domain, and Itk SH2 domain.
A, schematic representation of the GST-Itk fusion proteins
used in these and subsequent experiments. The TEC fusion protein
contains the COOH-terminal
-helix of the PH domain and the Btk motif
in addition to the PRR. B, murine CD4+ T cells
were stimulated by co-crosslinking CD3 and CD4 for 2 min. Lysates were
purifed over the indicated panel of GST fusion proteins. Bound
phosphoproteins were detected by Western blotting with the
anti-phosphotyrosine mAb 4G.10. Similar experiments were performed in
CD3- and pervanadate-stimulated Jurkat T cells with similar results.
The identities of these proteins were variously determined by
co-migration, by direct Western blotting, immunodepletion, and specific
re-immunoprecipitation from denatured binding assays followed by
anti-phosphotyrosine Western blotting. Migration positions of GST
fusion proteins are indicated by asterisks (*).
1, Cbl, Vav, SLP-76, ZAP-70, and LAT,
as indicated. PLC
1 was observed to bind the Itk SH3 domain by
Western blotting, and comigrated with the 150-kDa tyrosine phosphoprotein (data not shown). Cbl, Vav, SLP-76, and ZAP-70 were
identified by specific re-immunoprecipiation from denatured binding
assays (data not shown). Finally, LAT, which bound both PRR- and SH2
domain-containing fusion proteins, was identified by re-precipitation
with the Grb2 SH2 domain fusion protein (data not shown). Similar
results were obtained using Jurkat T cells (data not shown). It should
be noted that the Itk PRR is unlikely to interact directly with LAT,
which lacks an SH3 domain. Instead, this interaction is likely to be
bridged by Grb2, which binds to the Itk PRR via its amino-terminal SH3
domain (Fig. 3D and Ref. 49) and to LAT via its SH2 domain
(5). Gads, a Grb2-related adaptor protein might also function in this
manner (15). Since PLC
1, Cbl, Vav, SLP-76, and Grb2 all
co-immunoprecipitate with phosphorylated LAT (5), the binding of these
signaling molecules by distinct Itk protein domains implies that Itk
can interact with the LAT-nucleated signaling complex by more than one mechanism.

View larger version (37K):
[in a new window]
Fig. 5.
Predicted ligands for the Itk SH2 and SH3
domains. A, a degenerate phosphopeptide library
containing a fixed phosphotyrosine residue was applied to a GST-Itk SH2
domain affinity matrix. The eluted peptides were microsequenced and
relative enrichments were obtained as described under "Experimental
Procedures." pY+1, pY+2, and pY+3 indicate the first, second, and
third degenerate position carboxyl-terminal to the fixed
phosphotyrosine residue. Relative enrichments are presented for
strongly selected amino acids. There was no preferred selection
observed in positions NH2-terminal to the phosphotyrosine
resdiue. B, potential Tec kinase SH2 domain ligands were
scanned by eye for potential Itk SH2 domain binding sites. The
positions of the tyrosine residues in the full-length protein are
indicated at the right in parentheses. All the
sites presented are derived from human sequences and are cytoplasmic.
All of these sites, with the exception of those in BLNK, are known to
be phosphorylated in vivo. The PIDs for these proteins are
as follows: SLP-76 (g1082893), BLNK (g3406749), CD19 (g1705708), CD28
(g338445), ZAP-70 (g1177044), and SYK (g627588). C,
Sf9 cells were infected with the indicated baculoviruses.
Lysates were affinity purified over Itk SH3 and SH2 domain fusion
proteins; bound SLP-76 was detected by Western blotting for the
HA-epitope tag. D, Jurkat cells were treated with
pervanadate prior to lysis. Lysates were preincubated for 30 min at
4 °C with the phosphopeptides, as indicated. The GST-Itk SH2 domain
was added to this mixture and incubated for 90 min at 4 °C. Unbound
proteins were removed by rapid washes at 4 °C, and SLP-76 was
detected by Western blotting. E, Jurkat cells were
stimulated by CD3 cross-linking prior to lysis. Peptide competition
experiments were performed as in D, and the 36-kDa Grb2 SH2
domain-binding tyrosine phosphoprotein (LAT) was detected by
anti-phosphotyrosine Western blotting. F, lysates of
unstimulated Jurkat cells were preincubated with the indicated peptides
and binding assays were performed using the Itk SH3 domain. Bound
SLP-76 was detected by Western blotting. The GWYSKPPPPIP peptide used
as a control for the inhibition of SLP-76 binding was initially
generated based on the selection of Itk SH3 domain ligands from phage
display libraries.

View larger version (24K):
[in a new window]
Fig. 6.
Mutivalent interactions antagonize the
intramolecular interaction within Itk. A, Jurkat cells
were treated with pervanadate (PV) prior to lysis. Lysates
were preincubated with competing peptides, and binding assays were
performed. The high affinity SH3 domain-competing peptide, GWYSKPPPPIP,
was used at 100 µM. The SH2-competing peptide, SLP-76
pY145, was used at 1 mM. SLP-76 was detected by Western
blotting. B, Jurkat cells were stimulated by CD3
cross-linking (OKT3) or by pervanadate treatment prior to lysis.
Binding assays were performed in the presence or absence of 100 µM of the SH3 domain-competeting peptide GWYSKPPPPIP
(Pro). TEC2:3* includes an inactivating mutation in the
ligand binding pocket of the Itk-SH3 domain (W208K);
TEC2:PR* includes substitutions disrupting both
PXXP motifs in the Itk-PRR (P158A, P159A). Cbl, Vav, and LAT
were also detected by anti-phosphotyrosine Western blotting. In
addition, Vav was detected directly by Western blotting.

View larger version (19K):
[in a new window]
Fig. 7.
Reconstitution of the interaction between Itk
and SLP-76. A, Sf9 cells were infected with the
HA:SLP-76 baculovirus alone or together with the GST:Syk baculovirus.
SLP-76 was immunoprecipitated from lysates with the anti-HA mAb 12CA5.
After extensive rinsing, these immunoprecipitates were incubated with
lysates of Sf9 cells expressing full-length Itk. These binding
reactions were supplemented with recombinant GST-Grb2 or a mock
addition. Bound proteins were rinsed rapidly at 4 °C and detected by
Western blotting with the anti-Itk mAbs or anti-HA mAb 12CA5. The
results presented here are representative of three independent
experiments. B, quantitation of the effect of Grb2 on the
interaction between Itk and SLP-76 was performed by densitometry of
scanned images using NIH Image. Quantities of bound Itk were obtained
by subtracting out the signal intensity observed in the absence of the
SLP-76 bait; the resulting values were normalized to the amounts of the
immobilized SLP-76 bait itself (top panels in A).
To allow for a comparison between independent experiments, the Itk
bound to Syk-phosphorylated SLP-76 in the presence of recombinant Grb2
was arbitrarily designated 100%. Error bars show standard
deviations.

View larger version (28K):
[in a new window]
Fig. 8.
Itk antagonizes the effect of SLP-76 on NF-AT
transcription. A, Jurkat/TAg cells were transfected
with a NF-AT/SEAP reporter plus various combinations of SLP-76 and
either kinase-active or kinase-inactive Itk. B, Jurkat/TAg
were transfected with a NF-AT/SEAP reporter, SLP-76, and variants of
kinase-active Itk. Each transfection was assayed for SEAP production
after incubation in the absence of stimulation, after exposure to
plate-bound antibodies to CD3
(anti-TCR), and after treatment with
PMA (2 nM) and ionomycin (1 µM). The basal
and CD3
-stimulated responses of each transfection are expressed as a
percentage of the corresponding response to PMA and ionomycin. These
stimulations were performed in duplicate and the error bars
show the resulting standard deviations. These data are representative
of three independent experiments.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (31K):
[in a new window]
Fig. 9.
A model of the regulation of Itk.
Heavy dark lines indicate protein-protein interactions,
thin dark lines indicate flow through the cycle of
activation, and grey lines indicate phosphorylation events. Itk is
maintained in an inactive conformation by an intramolecular interaction
which involves its PRR, SH3 domain, and SH2 domain and sequesters the
PRR and SH3 domain (bottom). TCR cross-linking promotes the
recruitment of Itk to PtdIns(3,4,5)P3-containing lipid
rafts proximal to the receptor and enriched in Lck and LAT. This
colocalization promotes multivalent interactions between Itk and the
LAT signaling complex and therefore disrupts the intramolecular
interaction between the Itk PRR and SH3 domain. The resulting
conformational change enables the transphosphorylation of Itk by Lck
(top left). Subsequently, activated Itk autophosphorylates
the binding pocket of its SH3 domain, inactivating the SH3 domain and
increasing the accessiblity of the Itk PRR. The PRR then cooperates
with the PH domain and SH2 domain to stabilize Itk in LAT-nucleated
complexes containing PLC
1, an Itk substrate. This stabilization
depends on the association of the Itk PH domain with
PtdIns(3,4,5)P3-containing lipid rafts enriched in LAT, the
association of the Itk PRR with Grb2 bound to LAT, and the association
of the Itk SH2 domain with SLP-76 bound to LAT via GADS (top
right). Because Itk engages the LAT complex through sites which
may also be involved in the recruitment of Vav and Nck to the LAT
complex (PtdIns(3,4,5)P3 and Syk-phosphorylation sites in
SLP-76), the overexpression of Itk may exclude either Vav or Nck from
their sites of action. Finally, the dephosphorylation of Itk and
PtdIns(3,4,5)P3 allows the termination of signaling.
The enrichment of Itk in these raft-related structures could contribute
to the function of Itk in a number of ways. First, the colocalization
of Itk with Lck could promote the transphosphorylation of Itk by Lck.
Second, the colocalization of Itk with LAT could stabilize interactions
between these proteins. Third, since phosphatidylinositol phosphates
have been observed to be enriched in rafts, the localization of Itk in
these raft-related structures could favor the specific phosphorylation
and activation of PLC
1 molecules poised to hydrolyze their
substrates (70, 82). As expected, the inactivation of the lipid binding
pocket of the Itk PH domain prevented the association of Itk with these
raft-like structures and inhibited the transphosphorylation of Itk.
The association of Itk with Jurkat-derived raft-like structures was observed at all times, regardless of the activation state of the Jurkat cells. Given that Tec kinases do not typically interact constitutively with the plasma membrane, and that the lipid binding properties of the Tec kinase PH domains are quite similar, we propose that the constitutive association of Itk with plasma membrane-derived raft-like structures is a unique feature of Jurkat T cells (37). This idea is supported by our inability to detect Itk in raft-like structures derived from resting murine thymocytes (data not shown). Since Jurkat cells do not express PTEN, a phosphatidylinositol 3'-phosphatase, the basal association of Itk with raft-like structures in Jurkat T cells may result from constitutively elevated levels of PtdIns(3,4,5)P3 in these cells.3
Notably, the constitutive association of Itk with Lck-containing raft-like structures did not result in constitutive Itk phosphorylation, demonstrating that the colocalization of Itk with Lck may be a prerequisite for Itk transphosphorylation, but is not sufficient for Itk transphosphorylation. Activation-induced changes in the conformation of Lck and Itk may regulate the transphosphorylation of Itk by Lck (83, 84). These changes could result in the activation of Lck and could increase the accessibility of the Src kinase transphosphorylation site in the Itk kinase domain. In support of this hypothesis, we have shown that multivalent interactions between Itk, SLP-76 and Grb2 can modify the conformation of Itk, as indicated by the increased accessibility of the Itk PRR and SH3 domain.
We expect that an interaction between the unphosphorylated Itk SH3 domain and SLP-76 will contribute to the generation of conformational changes in Itk upon its initial recruitment to the LAT·SLP-76 complex. As outlined above, we expect this to promote the transphosphorylation of Itk by Lck (see Fig. 9). Although Yablonski et al. (20) have shown that the TCR-induced phosphorylation of Itk can proceed in the absence of SLP-76, the phosphorylation of Itk at time points proximal to receptor cross-linking was not examined. It is possible that a more extensive kinetic analysis will reveal an influence of SLP-76 on the rate of Itk phosphorylation. Alternate biochemical interactions could contribute to the observed phosphorylation of Itk in the absence of SLP-76. For example, ZAP-70, which we have predicted will interact with the Itk SH2 domain, could provide a docking site capable of promoting the activation of Itk by Lck. In support of this hypothesis, the phosphorylation of Itk has recently been observed to depend on the expression of ZAP-70 (48).
Transphosphorylated Tec kinases rapidly autophosphorylate a tyrosine
residue which forms one of the binding pockets of the SH3 domain (53).
This phosphorylation should inactivate the SH3 domain of Itk, inducing
the dissociation of Itk from its SH3 domain ligands and stabilizing
interactions mediated by the Itk PRR (49). In contrast,
autophosphorylation should not influence the binding properties of the
Itk PH domain or SH2 domain. Consequently, we expect activated,
autophosphorylated Itk to engage substrate-containing complexes through
PH domain-, PRR-, and SH2 domain-mediated interactions. Since the PH
domain directs interactions with LAT-enriched light vesicles, the PRR
directs interactions with Grb2 and LAT, and the SH2 domain binds
SLP-76, it is likely that activated Itk interacts with the
raft-associated, LAT-nucleated signaling complex containing SLP-76 (see
Fig. 9). Recently Itk was observed to co-immunoprecipitate with LAT
following TCR stimulation, supporting this hypothesis (48). Thus, in
SLP-76-deficient Jurkat cells, a failure to recruit Itk to LAT may
prevent the phosphorylation and activation of the raft-associated,
LAT-bound pool of PLC
1, resulting in the defective activation of
calcium fluxes and MAPKs downstream of the TCR (Fig. 9).
In this article we also report that the overexpression of Itk suppresses transcription from NF-AT response elements. We propose that this effect depends on the competitive exclusion of effectors from their docking sites in the raft-associated LAT·SLP-76 complex rather than the normal function of Itk downstream of SLP-76. In support of this proposal, the suppression of transcription is independent of Itk kinase activity. Furthermore, the suppression of transcription requires precisely the domains which we expect to direct interactions between activated Itk and the raft-associated LAT·SLP-76 complex: the PH domain, PRR, and SH2 domain.
The effectors antagonized by Itk have not been identified, but may include Nck and Vav. Nck, a SH2 and SH3 domain-containing adaptor protein, engages SLP-76 via its SH2 domain and has been shown to collaborate with SLP-76 to promote the activation of NF-AT downstream of the TCR (85). Nck is capable of recruiting both PAK and WASP to SLP-76, and has been shown to promote actin polymerization downstream of SLP-76 (9, 75). Thus, the Itk SH2 domain, which can bind to Nck SH2 domain docking sites in SLP-76, could compete directly with Nck for access to these sites, resulting in the inhibition of NF-AT activation. The Itk PH domain and PRR could enable the Itk SH2 domain to compete more effectively for access to SLP-76 by stabilizing Itk in the LAT·SLP-76 complex. Vav, an exchange factor for the Rac and Cdc42 GTPases, can also bind SLP-76 through its SH2 domain (8). However, Vav can cooperate with SLP-76 to activate NF-AT downstream of the TCR in the absence of this interaction (74, 76). For this reason, it is unlikely that the overexpression of Itk antagonizes the effects of SLP-76 by directly interfering with an SH2 domain-mediated interaction between SLP-76 and Vav. Instead, the PRR- and SH2 domain-directed stabilization of the interaction between Itk and the raft-associated LAT·SLP-76 complex may enable the Itk PH domain to compete with the Vav PH domain for access to PtdIns(3,4,5)P3, an activator of Vav (86). Thus, the competitive exclusion of either Nck or Vav from the LAT·SLP-76 complex could explain the suppression of transcription from NF-AT response elements by Itk.
The data presented in this article are consistent with a model in which
Tec kinases are regulated by a reversible intramolecular interaction
that sequesters the homology domains, limiting the intermolecular
interactions of Tec kinases. In this model Tec kinases are recruited to
their sites of activation by mulitvalent interactions,
autophosphorylated within their SH3 domain, and targeted to downstream
effectors by their PH domain, PRR, and SH2 domain. Since many predicted
ligands of the Tec kinase SH2 domains are substrates of Syk kinases,
this model explains the placement of the Tec kinases downstream of the
Syk kinases as a consequence of the Syk-dependent
recruitment of Tec kinases to multimolecular complexes associated with
Tec kinase activators, such as Lck, and containing Tec kinase
substrates, such as PLC
1. In T cells this complex appears to be
nucleated by the ZAP-70 substrates LAT and SLP-76. A related complex,
nucleated by CD19 and/or BLNK, may mediate similar functions in B cells.
| |
ACKNOWLEDGEMENTS |
|---|
We thank L. Kane, A. Weiss, and R. Wange for generously communicating unpublished data, A. Rao for the pEF-HA expression vector, B. Druker for the 4G.10 antibody, and K. Schaefer, J. van Leeuwen, and R. Wange for critical reading of the manuscript.
| |
FOOTNOTES |
|---|
* This work was supported by the Council for Tobacco Research, National Institutes of Health Grants AI32494 (to L. J. B), HL03601 (to M. B. Y.), and GM56203 (to L. C. C.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Current address: Bldg. 37, Rm. 1C05, LCMB, DBS, NCI, National
Institutes of Health, 37 Convent Dr., MSC 4255, Bethesda, MD 20892-4255.
To whom correspondence should be addressed. Tel.:
508-856-8371; Fax: 508-856-8372; E-mail:
Leslie.Berg@umassmed.edu.
2 H. Wilcox, M. Wahl, O. Witte, and L. Berg, unpublished observations.
3 L. Kane and A. Weiss, personal communication.
| |
ABBREVIATIONS |
|---|
The abbreviations used are:
TCR, T cell
receptor;
PLC
1, phospholipase C
1;
PI3K, phosphatidylinositol
3'-kinase;
MAPK, mitogen-activated protein kinase;
SH2 or -3, Src
homology domains 2 or 3;
PH, pleckstrin homology;
PRR, proline-rich
region;
PtdIns(3, 4,5)P3, phosphatidylinositol
3,4,5-trisphosphate;
mAb, monoclonal antibody;
HA, hemagglutinin;
PCR, polymerase chain reaction;
GST, glutathione S-transferase;
PMA, phorbol 12-myristate 13-acetate;
GEM, glycosphingolipid-enriched
membranes.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Wange, R. L., and Samelson, L. E. (1996) Immunity 5, 197-205[CrossRef][Medline] [Order article via Infotrieve] |
| 2. | Tamir, I., and Cambier, J. C. (1998) Oncogene 17, 1353-1364[CrossRef][Medline] [Order article via Infotrieve] |
| 3. |
Hata, D.,
Kawakami, Y.,
Inagaki, N.,
Lantz, C. S.,
Kitamura, T.,
Khan, W. N.,
Maeda-Yamamoto, M.,
Miura, T.,
Han, W.,
Hartman, S. E.,
Yao, L.,
Nagai, H.,
Goldfeld, A. E.,
Alt, F. W.,
Galli, S. J.,
Witte, O. N.,
and Kawakami, T.
(1998)
J. Exp. Med.
187,
1235-1247 |
| 4. | Furlong, M. T., Mahrenholz, A. M., Kim, K. H., Ashendel, C. L., Harrison, M. L., and Geahlen, R. L. (1997) Biochim. Biophys. Acta 1355, 177-190[Medline] [Order article via Infotrieve] |
| 5. | Zhang, W., Sloan-Lancaster, J., Kitchen, J., Trible, R. P., and Samelson, L. E. (1998) Cell 92, 83-92[CrossRef][Medline] [Order article via Infotrieve] |
| 6. |
Wardenburg, J. B.,
Fu, C.,
Jackman, J. K.,
Flotow, H.,
Wilkinson, S. E.,
Williams, D. H.,
Johnson, R.,
Kong, G.,
Chan, A. C.,
and Findell, P. R.
(1996)
J. Biol. Chem.
271,
19641-19644 |
| 7. | Fu, C., Turck, C. W., Kurosaki, T., and Chan, A. C. (1998) Immunity 9, 93-103[CrossRef][Medline] [Order article via Infotrieve] |
| 8. | Wu, J., Motto, D. G., Koretzky, G. A., and Weiss, A. (1996) Immunity 4, 593-602[CrossRef][Medline] [Order article via Infotrieve] |
| 9. | Bubeck Wardenburg, J., Pappu, R., Bu, J. Y., Mayer, B., Chernoff, J., Straus, D., and Chan, A. C. (1998) Immunity 9, 607-616[CrossRef][Medline] [Order article via Infotrieve] |
| 10. |
Katzav, S.,
Sutherland, M.,
Packham, G.,
Yi, T. L.,
and Weiss, A.
(1994)
J. Biol. Chem.
269,
32579-32585 |
| 11. |
Pacini, S.,
Ulivieri, C.,
Di Somma, M. M.,
Isacchi, A.,
Lanfrancone, L.,
Pelicci, P. G.,
Telford, J. L.,
and Baldari, C. T.
(1998)
J. Biol. Chem.
273,
20487-20493 |
| 12. |
Lupher, M. L., Jr.,
Songyang, Z.,
Shoelson, S. E.,
Cantley, L. C.,
and Band, H.
(1997)
J. Biol. Chem.
272,
33140-33144 |
| 13. |
Pelosi, M.,
Di Bartolo, V.,
Mounier, V.,
Mege, D.,
Pascussi, J. M.,
Dufour, E.,
Blondel, A.,
and Acuto, O.
(1999)
J. Biol. Chem.
274,
14229-14237 |
| 14. | Zhang, W., Trible, R. P., and Samelson, L. E. (1998) Immunity 9, 239-246[CrossRef][Medline] [Order article via Infotrieve] |
| 15. | Liu, S. K., Fang, N., Koretzky, G. A., and McGlade, C. J. (1999) Curr. Biol. 9, 67-75[CrossRef][Medline] [Order article via Infotrieve] |
| 16. | Straus, D. B., and Weiss, A. (1992) Cell 70, 585-593[CrossRef] |